Impaired exercise capacity and skeletal muscle function in a mouse model of pulmonary inflammation

Journal of Applied Physiology

Volumn 114, Issue 9, 2013, Pages 1340-1350

  Tang, Kechun ^a   Murano, George ^a   Wagner, Harrieth ^a   Nogueira, Leonardo ^a   Wagner, Peter D ^a   Tang, Alisa ^a   Dalton, Nancy D ^a   Gu, Yusu ^a   Peterson, Kirk L ^a   Breen, Ellen C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiopoietin; Atrophy; Chronic obstructive pulmonary disease; Fatigue; PGC 1

Indexed keywords

ANGIOPOIETIN; ESTROGEN; PEPTIDE; SFTPC PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ATROPHY; BLOOD; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE MODEL; EXERCISE; FATIGUE; FEMALE; GENE EXPRESSION; GENETICS; HEART; LUNG; MALE; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PGC-1; PHYSIOLOGY; PROMOTER REGION; SEXUAL DEVELOPMENT; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANGIOPOIETIN; ATROPHY; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; FATIGUE; PGC-1;

ANGIOPOIETINS; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GENE EXPRESSION; HEART; LUNG; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; PEPTIDES; PHYSICAL EXERTION; PROMOTER REGIONS, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX CHARACTERISTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878621949     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00607.2012     Document Type: Article

References (60)

1. Adhikari AS, Singh BN, Rao KS, Rao Ch M. alphaB-crystallin, a small heat shock protein, modulates NF-kappaB activity in a phosphorylationdependent manner and protects muscle myoblasts from TNF-alpha induced cytotoxicity. Biochim Biophys Acta 1813:1532-1542, 2011.
2. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, Rybkin II, Shelton JM, Manieri M, Cinti S, Schoen FJ, Bassel-Duby R, Rosenzweig A, Ingwall JS, Spiegelman BM. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1:259-271, 2005. (Pubitemid 43960608)
3. Bale TL, Hoshijima M, Gu Y, Dalton N, Anderson KR, Lee KF, Rivier J, Chien KR, Vale WW, Peterson KL. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. Proc Natl Acad Sci USA 101:3697-3702, 2004. (Pubitemid 38338257)
4. Barclay CJ. Modelling diffusive O2 supply to isolated preparations of mammalian skeletal and cardiac muscle. J Muscle Res Cell Motil 26:225-235, 2005. (Pubitemid 41739981)
5. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97:1382-1391, 1998. (Pubitemid 28182677)
6. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97:1375-1381, 1998. (Pubitemid 28182676)
7. Burchfield JS, Dong JW, Sakata Y, Gao F, Tzeng HP, Topkara VK, Entman ML, Sivasubramanian N, Mann DL. The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart. Circ Heart Fail 3:157-164, 2010.
8. Cai D, Xaymardan M, Holm JM, Zheng J, Kizer JR, Edelberg JM. Age-associated impairment in TNF-alpha cardioprotection from myocardial infarction. Am J Physiol Heart Circ Physiol 285:H463-H469, 2003. (Pubitemid 36885874)
9. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:549-555, 2008. (Pubitemid 351669185)
10. Creutzberg EC, Schols AM, Weling-Scheepers CA, Buurman WA, Wouters EF. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:745-752, 2000. (Pubitemid 30171726)
11. Creutzberg EC, Wouters EF, Vanderhoven-Augustin IM, Dentener MA, Schols AM. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:1239-1245, 2000.
12. Das A, Acharya S, Gottipati KR, McKnight JB, Chandru H, Alcorn JL, Boggaram V. Thyroid transcription factor-1 (TTF-1) gene: identification of ZBP-89, Sp1, and TTF-1 sites in the promoter and regulation by TNF-alpha in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 301:L427-L440, 2011.
13. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factoralpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150:1453-1455, 1994. (Pubitemid 24356667)
14. Dibbs ZI, Diwan A, Nemoto S, De Freitas G, Abdellatif M, Carabello BA, Spinale FG, Feuerstein G, Sivasubramanian N, Mann DL. Targeted overexpression of transmembrane tumor necrosis factor provokes a concentric cardiac hypertrophic phenotype. Circulation 108:1002-1008, 2003. (Pubitemid 37048232)
15. Diwan A, Dibbs Z, Nemoto S, De Freitas G, Carabello BA, Sivasubramanian N, Wilson EM, Spinale FG, Mann DL. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation 109:262-268, 2004. (Pubitemid 38114149)
16. Eisele PS, Salatino S, Sobek J, Hottiger MO, Handschin C. The peroxisome proliferator-activated receptor gamma coactivator 1alpha/beta (PGC-1) coactivators repress the transcriptional activity of NF-kappaB in skeletal muscle cells. J Biol Chem 288:2246-2260, 2013.
17. Fujita M, Ikegame S, Ye Q, Harada E, Ouchi H, Inoshima I, Watanabe K, Mason RJ, Nakanishi Y. Attenuation of pulmonary hypertension, but not emphysematous change, by breeding emphysema model mice at sea level. Cytokine 41:286-292, 2008.
18. Fujita M, Mason RJ, Cool C, Shannon JM, Hara N, Fagan KA. Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression. J Appl Physiol 93:2162-2170, 2002. (Pubitemid 35379344)
19. Fujita M, Shannon JM, Irvin CG, Fagan KA, Cool C, Augustin A, Mason RJ. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 280:L39-L49, 2001.
20. Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 11:63, 2010.
21. GOLD. Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. [Available from: http://www.goldcopd.org/].
22. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 30:73-79, 2007. (Pubitemid 47074009)
23. Gosker HR, Langen RC, Bracke KR, Joos GF, Brusselle GG, Steele C, Ward KA, Wouters EF, Schols AM. Extrapulmonary manifestations of COPD in a mouse model of chronic cigarette smoke exposure. Am J Respir Cell Mol Biol 40:710-716, 2009.
24. Haegens A, Schols AM, Gorissen SH, Van Essen AL, Snepvangers F, Gray DA, Shoelson SE, Langen RC. NF-κB activation and polyubiquitin conjugation are required for pulmonary inflammation-induced diaphragm atrophy. Am J Physiol Lung Cell Mol Physiol 302:L103-L110, 2012.
25. Higuchi Y, Chan TO, Brown MA, Zhang J, De George BR Jr, Funakoshi H, Gibson G, McTiernan CF, Kubota T, Jones WK, Feldman AM. Cardioprotection afforded by NF-kappaB ablation is associated with activation of Akt in mice overexpressing TNF-alpha. Am J Physiol Heart Circ Physiol 290:H590-H598, 2006.
26. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589-600, 2007. (Pubitemid 46206082)
27. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 121:2278-2289, 2011.
28. Kadokami T, McTiernan CF, Kubota T, Frye CS, Feldman AM. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J Clin Invest 106:589-597, 2000. (Pubitemid 30666392)
29. Kovacs EJ. Aging, traumatic injury, and estrogen treatment. Exp Gerontol 40:549-555, 2005. (Pubitemid 41074800)
30. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factoralpha. Circ Res 81:627-635, 1997. (Pubitemid 27432751)
31. Lahm T, Crisostomo PR, Markel TA, Wang M, Wang Y, Weil B, Meldrum DR. Exogenous estrogen rapidly attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction. Shock 30:660-667, 2008.
32. Langen RC, Haegens A, Vernooy JH, Wouters EF, De Winther MP, Carlsen H, Steele C, Shoelson SE, Schols AM. NF-kappaB activation Is required for the transition of pulmonary inflammation to muscle atrophy. Am J Respir Cell Mol Biol 47:288-297, 2012.
33. Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, Janssen-Heininger YM. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 35:689-696, 2006. (Pubitemid 44901858)
34. Lecour S, James RW. When are pro-inflammatory cytokines SAFE in heart failure? Eur Heart J 32:680-685, 2011.
35. Li X, Moody MR, Engel D, Walker S, Clubb FJ Jr, Sivasubramanian N, Mann DL, Reid MB. Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102:1690-1696, 2000.
36. Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, Reid MB. TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17:1048-1057, 2003. (Pubitemid 36676391)
37. Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J 12:871-880, 1998. (Pubitemid 28294677)
38. Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA 97:12746-12751, 2000.
39. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801, 2002.
40. Maher AC, Akhtar M, Tarnopolsky MA. Men supplemented with 17beta-estradiol have increased beta-oxidation capacity in skeletal muscle. Physiol Genomics 42:342-347, 2010.
41. Miyazaki Y, Araki K, Vesin C, Garcia I, Kapanci Y, Whitsett JA, Piguet PF, Vassalli P. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest 96:250-259, 1995.
42. Piehl-Aulin K, Jones I, Lindvall B, Magnuson A, Abdel-Halim SM. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease. Respiration 78:191-196, 2009.
43. Remels AH, Gosker HR, Schrauwen P, Hommelberg PP, Sliwinski P, Polkey M, Galdiz J, Wouters EF, Langen RC, Schols AM. TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J 24:5052-5062, 2010.
44. Renvall MJ, Friedman P, Ramsdell JW. Predictors of body mass index in patients with moderate to severe emphysema. COPD 6:432-436, 2009.
45. Resta TC, Kanagy NL, Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol 280:L88-L97, 2001.
46. Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, Hevener AL. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab 298:E304-E319, 2010.
47. Rosenblatt JD, Kuzon WM Jr, Plyley MJ, Pynn BR, McKee NH. A histochemical method for the simultaneous demonstration of capillaries and fiber type in skeletal muscle. Stain Technol 62:85-92, 1987. (Pubitemid 17080009)
48. Sandri M, Lin J, Handschin C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103:16260-16265, 2006. (Pubitemid 44715184)
49. Sivasubramanian N, Coker ML, Kurrelmeyer KM, MacLellan WR, De Mayo FJ, Spinale FG, Mann DL. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 104:826-831, 2001. (Pubitemid 32762683)
50. Sugiura T, Ito N, Goto K, Naito H, Yoshioka T, Powers SK. Estrogen administration attenuates immobilization-induced skeletal muscle atrophy in male rats. J Physiol Sci: 393-399, 2006. (Pubitemid 46974945)
51. Szalay L, Shimizu T, Suzuki T, Yu HP, Choudhry MA, Schwacha MG, Rue LW, 3rd Bland KI, Chaudry IH. Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression. Am J Physiol Regul Integr Comp Physiol 290:R812-R818, 2006.
52. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross J, Jr. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94:1109-1117, 1996. (Pubitemid 26292868)
53. Tang K, Breen EC, Gerber HP, Ferrara NM, Wagner PD. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18:63-69, 2004. (Pubitemid 39319487)
54. Tang K, Wagner PD, Breen EC. TNF-alpha-mediated reduction in PGC-1alpha may impair skeletal muscle function after cigarette smoke exposure. J Cell Physiol 222:320-327, 2010.
55. Tanni SE, Pelegrino NR, Angeleli AY, Correa C, Godoy I. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm 7:29, 2010.
56. Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotalineinduced pulmonary hypertension. Vascul Pharmacol 45:358-367, 2006. (Pubitemid 44765298)
57. Uguccioni G, Hood DA. The importance of PGC-1alpha in contractile activity-induced mitochondrial adaptations. Am J Physiol Endocrinol Metab 300:E361-E371, 2011.
58. Van Den Borst B, Koster A, Yu B, Gosker HR, Meibohm B, Bauer DC, Kritchevsky SB, Liu Y, Newman AB, Harris TB, Schols AM. Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax 66:961-969, 2011.
59. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31:492-501, 2008.
60. Zuo L, Nogueira L, Hogan MC. Effect of pulmonary TNF-α overexpression on mouse isolated skeletal muscle function. Am J Physiol Regul Integr Comp Physiol 301:R1025-R1031, 2011.